Overview
Infermedica provides clinical AI triage for digital patient access, call centers, and pre-visit intake. The system assesses symptoms and recommends an appropriate level of care; MGP is certified as a Class IIb medical device under the EU MDR.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2024, 17 days late). 2 of 6 audited by a statutory auditor.
- 202528/06/2026
- 202401/08/2025
- 202326/06/2024
- 202212/07/2023
- 202115/07/2022
- 202020/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical triage system
- Symptom assessment
- Care-level recommendation
- Telephone triage support
- Pre-visit intake
Website technology
- Website
- Nuxt
- Contact and booking
- HubSpot
- Analytics and marketing
- Google Tag Manager
Trademarks
Infermedica holds 7 active trademarks registered with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2012.
| Mark | Protected until | |
|---|---|---|
| Infermedica Follow-up(word) | Jul 11, 2032 | |
| Infermedica Triage(word) | Jul 11, 2032 | |
| Infermedica Intake(word) | Jul 11, 2032 | |
| Symptomate | May 19, 2030 | |
| Symptomate(word) | Dec 20, 2028 |
Authorized Representatives
Manner of representation
For the submission of declarations of will on behalf of the company, in the case of a multi-member management board, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required. In the case of a one-person management board, the sole member of the management board submits all declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Infermedica Inc. | 185 | $5,094,340.90 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-06-01.
37 2490 0005 0000 4600 9136 6485- 49 2490 0005 0000 4600 7765 2506
- 64 2490 0005 0000 4520 6165 1000
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 24, 2015 | Transformation registered |
Public aid
4 public aid cases recorded, with a total value of $30,694.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,758$9,758 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $8,943$8,943 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $8,699$8,699 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-02-01 | 762032 - Al-medicare - disruptive artificial intelligence engine to facilitate rapid low cost development of specialist e-health applications for smart decision making in medical pre-diagnosis | $56,352$56,352 | 1.1.31 - Horizon 2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nexus Polskasp. z o.o. | $13,510,195.77 | nexuspolska.pl | ||
| Momentumsp. z o.o. | $6,437,352.90 | themomentum.ai | ||
| Cloudimedsp. z o.o. | $4,150,925.84 | cloudimed.pl | ||
| Medidesksp. z o.o. | $3,855,726.22 | medidesk.com | ||
| Dreryksp. z o.o. | $3,272,071.46 | dreryk.pl | ||
| Info-Lidersp. z o.o. | $2,750,711.38 | info-lider.pl | ||
| TK-MEDsp. z o.o. | $2,390,311.13 | tk-med.pl | ||
| Medcore Projectsp. z o.o. | $2,028,836.27 | medcoreproject.pl | ||
| Infotower Business Solutionssp. z o.o. | $1,903,379.58 | infotower.pl | ||
| Proassistsp. z o.o. | $1,571,513.30 | proassist.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-30 | Share capital increase (18,130,900.00 PLN → 18,679,600.00 PLN) | |
| 2025-03-19 | Share capital increase (16,887,050.00 PLN → 18,130,900.00 PLN) | |
| 2024-03-12 | Share capital increase (14,910,700.00 PLN → 16,887,050.00 PLN) | |
| 2023-02-28 | Share capital increase (13,064,800.00 PLN → 14,910,700.00 PLN) | |
| 2022-08-29 | Share capital increase (10,753,700.00 PLN → 13,064,800.00 PLN) |
FAQ
Last updated: 2026-10-07